NCT00209456View on ClinicalTrials.gov

Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia

PHASE3CompletedINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

November 30, 2003

Conditions
Lewy Body DementiaNon-DLB DementiaAlzheimer'sVascular Dementia
Interventions
DRUG

DatSCAN

Trial Locations (1)

Unknown

Amersham Buchler GmbH Co. KG, Ismaning

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
lead

GE Healthcare

INDUSTRY